These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16628259)

  • 21. Ranolazine (Ranexa) for chronic stable angina.
    Ndegwa S
    Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranolazine for chronic stable angina.
    Nash DT; Nash SD
    Lancet; 2008 Oct; 372(9646):1335-41. PubMed ID: 18929905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
    Conti CR
    Clin Cardiol; 2008 Jul; 31(7):295-6. PubMed ID: 18636470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial fatty acid oxidation (pFOX) inhibition: a new therapy for chronic stable angina.
    Conti CR
    Clin Cardiol; 2003 Apr; 26(4):161-2. PubMed ID: 12708620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. At the dawn of a new era in treating angina pectoris, or just another antianginal drug? Some considerations about ranolazine.
    Bălan H
    Rom J Intern Med; 2010; 48(4):361-9. PubMed ID: 21528766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranolazine as add-on therapy for patients with severe chronic angina.
    Hooper JS; Busti AJ
    JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113810
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
    Chaitman BR; Skettino SL; Parker JO; Hanley P; Meluzin J; Kuch J; Pepine CJ; Wang W; Nelson JJ; Hebert DA; Wolff AA;
    J Am Coll Cardiol; 2004 Apr; 43(8):1375-82. PubMed ID: 15093870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ranolazine: a novel therapeutic option in chronic stable angina.
    Jose J; Jimmy B; Saravu K; Shastry BA
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):596-9. PubMed ID: 18604102
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
    Chaitman BR
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S47-64. PubMed ID: 15378131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ranolazine (ranexa) for chronic angina.
    Med Lett Drugs Ther; 2006 Jun; 48(1236):46-7. PubMed ID: 16770296
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
    Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
    Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial.
    Weisz G; Farzaneh-Far R; Ben-Yehuda O; Debruyne B; Montalescot G; Lerman A; Mahmud E; Alexander KP; Ohman EM; White HD; Olmsted A; Walker GA; Stone GW
    Am Heart J; 2013 Dec; 166(6):953-959.e3. PubMed ID: 24268208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranolazine: new drug. Stable angina: not worth the risk.
    Prescrire Int; 2009 Aug; 18(102):148-7. PubMed ID: 19743543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain.
    Hidalgo-Vega A; Ramos-Goñi JM; Villoro R
    Eur J Health Econ; 2014 Dec; 15(9):917-25. PubMed ID: 24122303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ranolazine--a nicely timed new medical therapy for stable angina.
    Jackson G
    Int J Clin Pract; 2007 Jul; 61(7):1063. PubMed ID: 17577287
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
    Morrow DA; Scirica BM; Karwatowska-Prokopczuk E; Murphy SA; Budaj A; Varshavsky S; Wolff AA; Skene A; McCabe CH; Braunwald E;
    JAMA; 2007 Apr; 297(16):1775-83. PubMed ID: 17456819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.
    Pepine CJ; Wolff AA
    Am J Cardiol; 1999 Jul; 84(1):46-50. PubMed ID: 10404850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranolazine: a review of its use in chronic stable angina pectoris.
    Siddiqui MA; Keam SJ
    Drugs; 2006; 66(5):693-710. PubMed ID: 16620147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.